A3V (p.Ala3Val) variant of SLC35A2 (UDP-galactose translocator)

A3V (p.Ala3Val) in SLC35A2 (UDP-galactose translocator) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as benign in the context of SLC35A2-congenital disorder of glycosylation. The available variant effect predictions contribute to a CATVariant prioritization score of 0.40 / 1. The record also includes population frequency data and structural context.

A3V (p.Ala3Val) variant details